Article Versions Notes

Cai M, Lai W, Chen H, Cao D, Zhang B, Wang F, Xian M, Wang S. Puerarin Targets HIF-1α to Modulate Hypoxia-Related Sphingolipid Metabolism in Diabetic Hepatopathy via the SPTLC2/Ceramide Pathway. Pharmaceuticals. 2025; 18(3):398. https://doi.org/10.3390/ph18030398

Cai, Mangui, Wenxi Lai, Huien Chen, Dongmin Cao, Boyan Zhang, Feng Wang, Minghua Xian, and Shumei Wang. 2025. "Puerarin Targets HIF-1α to Modulate Hypoxia-Related Sphingolipid Metabolism in Diabetic Hepatopathy via the SPTLC2/Ceramide Pathway" Pharmaceuticals 18, no. 3: 398. https://doi.org/10.3390/ph18030398

Cai, M., Lai, W., Chen, H., Cao, D., Zhang, B., Wang, F., Xian, M., & Wang, S. (2025). Puerarin Targets HIF-1α to Modulate Hypoxia-Related Sphingolipid Metabolism in Diabetic Hepatopathy via the SPTLC2/Ceramide Pathway. Pharmaceuticals, 18(3), 398. https://doi.org/10.3390/ph18030398